VIVE - ビビ―ブ・メディカル (Viveve Medical Inc.)

VIVEのニュース

   Viveve Medical, Inc.: Viveve to Host Conference Call on August 12, 2021 to Report Second Quarter Financial Results and Provide Corporate Update  2021/08/05 12:32:00 FinanzNachrichten
ENGLEWOOD, CO / ACCESSWIRE / August 5, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women''s intimate health, today announced that it will report its second qua
   Viveve Medical, Inc.: Viveve Announces Continued Expansion of IP Portfolio with Issuance of Canadian Patent  2021/08/03 12:32:00 FinanzNachrichten
ENGLEWOOD, CO / ACCESSWIRE / August 3, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women''s intimate health, today announced that the Canadian Intellectual Pro
   Viveve Medical, Inc.: Viveve Announces Issuance of New Device and Methods Patent in U.S.  2021/06/10 12:32:00 FinanzNachrichten
ENGLEWOOD, CO / ACCESSWIRE / June 10, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women''s intimate health, today announced that the United States Patent and T
   Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q1 2021 Results - Earnings Call Transcript  2021/05/14 03:45:03 Seeking Alpha
   Viveve Medical Inc Shares Near 52-Week Low - Market Mover  2021/05/13 22:30:00 Kwhen Finance
Viveve Medical Inc (VIVE) shares closed today at 0.4% above its 52 week low of $2.40, giving the company a market cap of $24M. The stock is currently down 48.7% year-to-date, down 59.5% over the past 12 months, and up 26677.8% over the past five years. This week, the Dow Jones Industrial Average fell 1.0%, and the S&P 500 fell 1.3%. Trading Activity Trading volume this week was 50.6% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -303.0% The company's stock price performance over the past 12 months lags the peer average by -298.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Viveve Medical, Inc.: Viveve Announces Issuance of New Device and Methods Patent in U.S.  2021/06/10 12:32:00 FinanzNachrichten
ENGLEWOOD, CO / ACCESSWIRE / June 10, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women''s intimate health, today announced that the United States Patent and T
   Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q1 2021 Results - Earnings Call Transcript  2021/05/14 03:45:03 Seeking Alpha
   Viveve Medical Inc Shares Near 52-Week Low - Market Mover  2021/05/13 22:30:00 Kwhen Finance
Viveve Medical Inc (VIVE) shares closed today at 0.4% above its 52 week low of $2.40, giving the company a market cap of $24M. The stock is currently down 48.7% year-to-date, down 59.5% over the past 12 months, and up 26677.8% over the past five years. This week, the Dow Jones Industrial Average fell 1.0%, and the S&P 500 fell 1.3%. Trading Activity Trading volume this week was 50.6% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -303.0% The company's stock price performance over the past 12 months lags the peer average by -298.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Viveve Medical EPS misses by $0.29, beats on revenue  2021/05/13 20:36:48 Seeking Alpha
   Viveve Medical, Inc.: Viveve Reports First Quarter 2021 Financial Results and Provides Corporate Update  2021/05/13 20:08:00 FinanzNachrichten
Pivotal SUI PURSUIT trial enrollment underway and accelerating Total revenue of $1.5M for Q1 including sale of 2,450 consumable treatment tips Strengthened patent portfolio in key Asia Pacific mark
   Viveve Medical, Inc.: Viveve Announces Issuance of New Device and Methods Patent in U.S.  2021/06/10 12:32:00 FinanzNachrichten
ENGLEWOOD, CO / ACCESSWIRE / June 10, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women''s intimate health, today announced that the United States Patent and T
   Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q1 2021 Results - Earnings Call Transcript  2021/05/14 03:45:03 Seeking Alpha
   Viveve Medical Inc Shares Near 52-Week Low - Market Mover  2021/05/13 22:30:00 Kwhen Finance
Viveve Medical Inc (VIVE) shares closed today at 0.4% above its 52 week low of $2.40, giving the company a market cap of $24M. The stock is currently down 48.7% year-to-date, down 59.5% over the past 12 months, and up 26677.8% over the past five years. This week, the Dow Jones Industrial Average fell 1.0%, and the S&P 500 fell 1.3%. Trading Activity Trading volume this week was 50.6% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -303.0% The company's stock price performance over the past 12 months lags the peer average by -298.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Viveve Medical EPS misses by $0.29, beats on revenue  2021/05/13 20:36:48 Seeking Alpha
   Viveve Medical, Inc.: Viveve Reports First Quarter 2021 Financial Results and Provides Corporate Update  2021/05/13 20:08:00 FinanzNachrichten
Pivotal SUI PURSUIT trial enrollment underway and accelerating Total revenue of $1.5M for Q1 including sale of 2,450 consumable treatment tips Strengthened patent portfolio in key Asia Pacific mark

calendar